PrimeRFP SCOUT · Federal Contract Recompete Brief

HT940623F0025Clinical chemical analyzers and reagents — Ortho-Clinical Diagnostics, Inc

Ortho-Clinical Diagnostics, Inc holds $57.6M across 1,615 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent V797D60637. Competition previously drew 5 offers. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Defense Health Agency
Awarding office
Ortho-Clinical Diagnostics, Inc
Recipient
Sep 30, 2026
PoP end
$2.1M
Obligated
$3.3M
Potential
334516
NAICS
6550
PSC
5 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics, Inc — $90

Contract facts

Federal
Contract numberHT940623F0025
Also listed asHT9406-23-F-0025
Also listed asV797D60637-HT940623F0025
AgencyDefense Health Agency
Awarding officeDefense Health Agency
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentOrtho-Clinical Diagnostics, Inc
CAGE1C0L5
UEIJG5JF2JQJ121
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6550
Parent IDIQ / IDVV797D60637
Place of performanceJACKSONVILLE VT
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitationHT940622Q0002
PoP startJun 30, 2023
PoP end (current)Sep 30, 2026
PoP end (w/ options)Jun 29, 2028
Obligated$2.1M
Current value$2.2M
Potential value$3.3M

CLINICAL CHEMICAL ANALYZERS AND REAGENTS is a federal award for Defense Health Agency held by Ortho-Clinical Diagnostics, Inc. Estimated value $3.3M ($2.1M obligated). Current period of performance ends Sep 30, 2026 (potential Jun 29, 2028). Last award drew 5 bidders. Place of performance: JACKSONVILLE VT. Related solicitation HT940622Q0002.

Recompete timing

Public
Expiring in 39 days

Current PoP ends Sep 30, 2026 (39 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics, Inc$57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($57.6M) · all agencies
Department of Veterans Affairs (VA)$26.2M · 45%Department of Defense (DOD)$22.1M · 38%Department of Health and Human Services (HHS)$8.6M · 15%General Services Administration (GSA)$297K · 1%
Open full company profile

Related awards

Same parent · incumbent
75H71024F80169
FY2024 LAB VITROS7600 REAGENTS/SUPPLIES TO BE ORDERED ON AN "AS NEEDED" BASIS, PART OF CPT…
$2.1M
Aug 31, 2026
FA466121F0075
VITROS CHEMICAL ANALYZER MAINTENANCE AND CALIBRATION
$336K
Aug 31, 2026
36C25925N0518
BLOOD BANK GEL ANALYZER COST PER TEST - SLC
$114K
Sep 6, 2026
36C25025N0968
BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES
$239K
Sep 14, 2026
FA489721F0042
CHEM ANALYZER SERVICES - EXERCISE OPTION YEAR 1
$717K
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract HT940623F0025?

HT940623F0025 (Clinical chemical analyzers and reagents) is a Defense Health Agency award with a potential value of $3.3M, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT9406-23-F-0025?

HT9406-23-F-0025 is the dashed form of PIID HT940623F0025 (Clinical chemical analyzers and reagents), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT940623F0025?

Defense Health Agency awarded HT940623F0025 to Ortho-Clinical Diagnostics, Inc (potential $3.3M).

Who is the incumbent on HT940623F0025?

Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Ortho-Clinical Diagnostics, Inc’s HT940623F0025 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on HT940623F0025 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HT940623F0025